FFG
BCAB icon

Forum Finance Group’s BioAtla BCAB Stock Holding History

Forum Finance Group’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
+400
New +$1.7K ﹤0.01% 333

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Forum Finance Group's BCAB Position: Q2 2026 in Review

Forum Finance Group opened a new position in BioAtla (BCAB) in Q2 2026: 400 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #333 among its holdings.

21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Forum Finance Group held 400 shares of BioAtla worth $1K as of Q2 2026.
  • BioAtla was a new Forum Finance Group position in Q2 2026.
  • BioAtla made up ﹤0.01% of Forum Finance Group's portfolio in Q2 2026, its #333 holding.
  • 21 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on Forum Finance Group's 13F filing for Q2 2026, filed 14 Aug 2026.